carvedilol has been researched along with Pheochromocytoma, Extra-Adrenal in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Suzuki, K | 1 |
| Miyake, T | 1 |
| Okada, H | 1 |
| Yamaji, F | 1 |
| Kitagawa, Y | 1 |
| Fukuta, T | 1 |
| Yasuda, R | 1 |
| Tanaka, Y | 1 |
| Okamoto, H | 1 |
| Nachi, S | 1 |
| Doi, T | 1 |
| Yoshida, T | 1 |
| Kumada, K | 1 |
| Yoshida, S | 1 |
| Ushikoshi, H | 1 |
| Toyoda, I | 1 |
| Ogura, S | 1 |
| Tsechelidis, I | 1 |
| El Darazi, E | 1 |
| Muteganya, R | 1 |
| Weyts, K | 1 |
| Goldman, S | 1 |
2 other studies available for carvedilol and Pheochromocytoma, Extra-Adrenal
| Article | Year |
|---|---|
Thyrotoxic and pheochromocytoma multisystem crisis: a case report.
Topics: Adrenal Gland Neoplasms; Adrenergic alpha-1 Receptor Antagonists; Carbazoles; Carvedilol; Diagnosis, | 2017 |
Failure of Classical β-Blocker Carvedilol to Deactivate Brown Adipose Tissue in a Patient With Pheochromocytoma.
Topics: Adipose Tissue, Brown; Adrenal Gland Neoplasms; Adrenergic beta-Antagonists; Adult; Carbazoles; Carv | 2018 |